Heme Reports (@hemereports) 's Twitter Profile
Heme Reports

@hemereports

Case-based discussions of hematologic malignancies | Not Medical Advice | Cases inspired by real patients but identifying features changed | #ExpertsWithinReach

ID: 1481090879536439297

linkhttp://www.hemereports.com calendar_today12-01-2022 02:29:32

45 Tweet

2,2K Takipçi

13 Takip Edilen

Heme Reports (@hemereports) 's Twitter Profile Photo

T-minus 1 hr for this #TwitterSpaces discussion on #ASH22 abstracts on myeloid malignancies with a focus on how the two new classifications (ICC and WHO HEM5) impact disease subclassification - join us! cc: Kamran Mirza MD PhD - کامران مرزا Sanam Loghavi, MD صنم لغوی 🔬🧬 Anand Patel Naveen Pemmaraju, MD Nitin Jain

Heme Reports (@hemereports) 's Twitter Profile Photo

📢📢Do you want to be automatically registered for Heme Reports sessions? If so, fill out this form: bit.ly/hemereports-si… 📰 #ExpertsWithinReach #hemepath #leusm #lymsm #MDSsm #MPNsm #BPDCN cc: @kmirza Nitin Jain Sanam Loghavi, MD صنم لغوی 🔬🧬 Naveen Pemmaraju, MD Anand Patel

📢📢Do you want to be automatically registered for <a href="/HemeReports/">Heme Reports</a> sessions? 

If so, fill out this form: bit.ly/hemereports-si… 📰

#ExpertsWithinReach #hemepath #leusm #lymsm #MDSsm #MPNsm #BPDCN 

cc: @kmirza <a href="/NitinJainMD/">Nitin Jain</a> <a href="/sanamloghavi/">Sanam Loghavi, MD صنم لغوی 🔬🧬</a> <a href="/doctorpemm/">Naveen Pemmaraju, MD</a> <a href="/Anand_88_Patel/">Anand Patel</a>
Heme Reports (@hemereports) 's Twitter Profile Photo

As you prepare for @hemereports S2E3 on blast-phase MPN, be sure to checkout the recording for S2E2 on BPDCN! Find all previous recordings here: hemereports.com/archive #ExpertsWithinReach cc: Naveen Pemmaraju, MD Nitin Jain Sanam Loghavi, MD صنم لغوی 🔬🧬 Anand Patel @kmirza youtu.be/ldVfBOL98vY

Sanam Loghavi, MD صنم لغوی 🔬🧬 (@sanamloghavi) 's Twitter Profile Photo

Season 2, episode 4 of Heme Reports tonight… with leading AML experts Naval Daver, M.D. Jessica Altman, MD Eunice Wang MD Dr. Sasha Perl. We will discuss FLT3 m AML & hope to cover revised risk stratification, implications for transplant, combination therapies, new FLT3i approvals, the

Heme Reports (@hemereports) 's Twitter Profile Photo

T-minus 20 minutes! Join us at 6:30 PM CT - there's still time to register! #ExpertsWithinReach #HemeReports AML with mutated FLT3